Literature DB >> 4177135

Significance of Rh-sensitization during pregnancy: its relation to a preventive programme.

J C Godel, D I Buchanan, J M Jarosch, M McHugh.   

Abstract

A study of the incidence of Rh-sensitization showed a 6.5% incidence of anti-D appearing for the first time during the last trimester of pregnancy. In 24 of the 29 subjects these antibodies were weak, and were found only when a sensitive technique using enzyme-treated Rh-deletion test cells was employed. The remaining five, however, had high-titre antibodies, which were associated with a positive Coombs test on cord blood.Rh-immune globulin administered at delivery resulted in disappearance of the anti-D in all but one of the subjects with weak antibody to whom it was given, suggesting that this treatment can reverse early sensitization. There was no effect when Rh-immune globulin was given to one subject with a high anti-D titre.Since sensitization has been found to occur frequently during the last trimester of pregnancy, an antenatal schedule of prophylaxis is advocated.

Mesh:

Substances:

Year:  1968        PMID: 4177135      PMCID: PMC1912706          DOI: 10.1136/bmj.4.5629.479

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  SPECIFIC INHIBITION OF ANTIBODY FORMATION BY PASSIVELY ADMINISTERED 19S AND 7S ANTIBODY.

Authors:  M S FINKELSTEIN; J W UHR
Journal:  Science       Date:  1964-10-02       Impact factor: 47.728

2.  THE TRANSPLACENTAL PASSAGE OF FOETAL RED BLOOD-CELLS AND THE PATHOGENESIS OF RH IMMUNISATION DURING PREGNANCY.

Authors:  A ZIPURSKY; J POLLOCK; P NEELANDS; B CHOWN; L G ISRAELS
Journal:  Lancet       Date:  1963-09-07       Impact factor: 79.321

3.  THE USE OF A PROTEOLYTIC ENZYME OF STREPTOMYCES GRISEUS (PROTEASE G) IN BLOOD BANKING: A PRELIMINARY ACCOUNT.

Authors:  D I BUCHANAN; K P DIERICH
Journal:  Transfusion       Date:  1965 Jan-Feb       Impact factor: 3.157

4.  IDENTIFICATION OF BLOOD GROUP ANTIGENS BY IMMUNOFLUORESCENCE AND ITS APPLICATION TO THE DETECTION OF THE TRANSPLACENTAL PASSAGE OF ERYTHROCYTES IN MOTHER AND CHILD.

Authors:  F COHEN; W W ZUELZER
Journal:  Vox Sang       Date:  1964 Jan-Feb       Impact factor: 2.144

5.  Blood genotypes-D-/-D- and Cde/-D-; transfusion therapy and some effects of multiple pregnancy.

Authors:  D I BUCHANAN
Journal:  Am J Clin Pathol       Date:  1956-01       Impact factor: 2.493

6.  Rh factor: prevention of isoimmunization and clinical trial on mothers.

Authors:  V J Freda; J G Gorman; W Pollack
Journal:  Science       Date:  1966-02-18       Impact factor: 47.728

7.  The pathogenesis and prevention of Rh immunization.

Authors:  A Zipursky; L G Israels
Journal:  Can Med Assoc J       Date:  1967-11-18       Impact factor: 8.262

8.  Suppression of Rh-immunization by passively administered anti-Rh.

Authors:  P L Mollison
Journal:  Br J Haematol       Date:  1968-01       Impact factor: 6.998

9.  Antibody synthesis at the cellular level. Antibody-induced suppression of 7S antibody synthesis.

Authors:  H Wigzell
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

  9 in total
  4 in total

1.  Rh prevention: a report and analysis of a national programme.

Authors:  J Eklund; H R Nevanlinna
Journal:  J Med Genet       Date:  1973-03       Impact factor: 6.318

2.  Prevention of primary Rh immunization: first report of the Western Canadian trial, 1966-1968.

Authors: 
Journal:  Can Med Assoc J       Date:  1969-06-14       Impact factor: 8.262

3.  Prevention of Rh-haemolytic disease: results of the Liverpool "low-risk" clinical trial.

Authors:  J C Woodrow; C A Clarke; R B McConnell; S H Towers; W T Donohoe
Journal:  Br Med J       Date:  1971-06-12

4.  Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis.

Authors:  Xiaohui Xie; Qiurong Fu; Ziwei Bao; Yi Zhang; Dan Zhou
Journal:  PLoS One       Date:  2020-03-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.